Company: IONQ
Filing Date: 2025-07-07
Form Type: 424B5
Source: 0001193125-25-155889
Chunk: 26

Company: IonQ, Inc.
Filing Date: 2025-07-07
Form: 424B5
Chunk 26
---
 submission to or filing with the Commission a registration statement under the Securities Act relating to, shares of common stock or securities convertible into or exercisable for shares of common stock pursuant to the conversion or exchange
of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or the settlement of RSUs (including net settlement), in each case outstanding on the date of the underwriting agreement and described in this
prospectus supplement (including the Pre-Funded Warrants and the Series A Warrants and the issuance of the warrants shares); (ii) grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of shares of our
common stock or securities convertible into or exercisable or exchangeable for shares of our common stock (whether upon the exercise of stock options or otherwise) to our employees, officers, directors, advisors, or consultants pursuant to the terms
of an equity compensation plan in effect as of the closing of this offering and described in this prospectus supplement, provided that any such recipient who is an executive officer or director enter into a
lock-up agreement with the underwriters covering the 60-day period; (iii) the issuance of, or submission to or filing with the Commission a registration statement
under the Securities Act relating to, shares of common stock pursuant to acquisitions or other similar strategic transactions that have been disclosed in the prospectus supplement; (iv) the issuance of, or submission to or filing with the
Commission a registration statement under the Securities Act relating to, shares of common stock, or securities convertible into, exercisable for, or which are otherwise exchangeable for, common stock, immediately following the closing of this
offering, in acquisitions or other similar strategic transactions (including the entry into any agreement providing for such issuance); (v) facilitating the establishment of a trading plan on behalf of a stockholder, officer, employee or
director of the Company to pursuant to Rule 10b5-1 under the Exchange Act for the sale, transfer or disposition of Common Stock; provided that such plan does not provide for the sale, transfer or disposition
of Common Stock during the Restricted Period; or (vi) filing of any registration statement on Form S-8 relating to securities granted or to be granted pursuant to any plan in effect on the date of the
underwriting agreement and described in this prospectus supplement or any assumed benefit plan pursuant to an acquisition or similar strategic transaction.

Our directors and executive officers (such persons, the “lock-up